SORT BY Relevancy
How might we look at genomics in office practice in Family Medicine? Dr. Jonas, your host for the Dr. Synonymous Show, will dream a bit about what we are doing now and what might be.
Responding to patients with painful situations is challenging in Family Medicine. We love our patients. They hurt- we help. But, their brain might get dysregulated by the pain via "wind-up" and potentially by opiate medications for persistent moderate or severe pain. With FDA tightening up on prescribing rules for , many more patients are seeing their doctor monthly. How do we respond to their frustrations at having to come in monthly for their pain management?
Pain is a paradox in Family Medicine. Listen in for further discussion.
Dr. Mansoor S. Mohammed is a recognized authority in the fields of medical genomics and personalized medicine.Prior to cofounding Younique Genomics, Dr. Mohammed served as the President and CEO of CombiMatrix Diagnostics where he oversaw the development of one of the most comprehensive genomics testing menus in the diagnostic industry. Prior to his tenure at CombiMatrix Diagnostics, Dr. Mohammed was the Director of Advanced Technologies at Quest Diagnostics, North America's largest reference laboratory. At Quest Diagnostics, he was honored with the Medical Innovation Award, the highest accolade given for excellence in medical research.
Prior to his role at Quest Diagnostics, Dr. Mohammed was a co-founder and Director of Research and Development at Spectral Genomics. Dr. Mohammed pioneered the development of commercial Comparative Genomic Hybridization (CGH) array technologies and was responsible for the design and launch of the industry's first commercially available CGH arrays. He was the co-primary author of the first peer-reviewed study utilizing CGH arrays in the clinical diagnosis of developmental abnormalities (2002) and later (2008) was the senior author of the first peer-reviewed study utilizing CGH arrays for clinical oncology purposes. Moreover, the CGH array technologies Dr. Mohammed helped to innovate became the basis for the discovery of genome copy number variations (CNVs). The latter has fundamentally altered and improved the way the human genome is viewed and interpreted, and has spawned thousands of studies and publications worldwide.
Most recently, Dr. Mohammed has worked with leading medical practitioners to become one of the first in the world to incorporate genome CNV analyses into a comprehensive approach to personalized medicine.
In this episode, we welcome Dr. Barbara Gitlitz (Principal Investigator of GoYLC), and young adult lung cancer survivors Sandy Jauregui and Jeff Julian to discuss the genomics of young adult lung cancer, clinical trials and targeted therapies. Survivor/Advocate spotlight on Katie Brown (VP, Survivorship, LUNGEVITY)
In this episode, we talk with Bonnie Addario (Founder, The Bonnie J. Addario Lung Cancer Foundation), Emily Bennett Taylor (Spokesperson/Patient Advocate) and Steven Young (President & COO, Addario Lung Cancer Medical Institute) about the international Genomics of Young Lung Cancer clinical/trial/study. Survivor Spotlight on Matthew Soblick.
In some cases of high-conflict divorce, a child allies himself strongly with one parent (the preferred parent or alienating parent) and rejects a relationship with the other parent (the target parent) without legitimate justification.
Children are the most vulnerable members of a family and it is only to be expected that a parent will find them a useful tool against the other parent. In its more subtle forms, it is near impossible to detect.
Why does this happen? What can be done about it? Why has there been opposition to recognizing parental alienation as a serious problem?
Join us as psychiatrist Bill Bernet discusses his work regarding this troubling situation.
William Bernet, M.D., is a graduate of Holy Cross College (summa cum laude) and Harvard Medical School. He is currently a professor emeritus at Vanderbilt University School of Medicine. He is board certified in general psychiatry, child psychiatry, and forensic psychiatry. As an expert in forensic psychiatry, Dr. Bernet has testified about 300 times in 20 states.
Dr. Bernet has written professional articles and chapters on a variety of subjects, including: group and individual therapy with children and adolescents; humor in psychotherapy; forensic child psychiatry; child maltreatment; true and false allegations of abuse; satanic ritual abuse; reincarnation; child custody and visitation; parental alienation; testimony regarding behavioral genomics; and risk management.
In 2007, Dr. Bernet and Judge Don R. Ash published Children of Divorce: A Practical Guide for Parents, Therapists, Attorneys, and Judges. Dr. Bernet edited Parental Alienation, DSM-5, and ICD-11, which was published in 2010. Dr. Bernet and his colleagues edited Parental Alienation: The Handbook for Mental Health and Legal Professionals, which was published in 2013.
On the Wednesday, February 4th 2015 broadcast at 8AM Pacific/11AM Eastern our special guest is Dietrich Stephan, Ph.D. (@dasphd) the Chairman of the Department of Human Genetics at the University of Pittsburgh, and Associate Director of the Institute for Personalized Medicine of Pitt/UPMC where he leads the efforts in population genetics and translational acceleration.
Prior to his current position, Dr. Stephan founded and served as President and CEO of Silicon Valley Biosystems, which offers genome-based diagnostics at the point of care.
Prior to SVBio, he led the Gene Partnership Project at Children’s Hospital Boston/Harvard Medical School, founded several companies in the San Francisco Bay Area, and served on the leadership team at the Translational Genomics Research Institute.
He has been awarded the Bio-IT World Grand Prize, the “Most Influential in Bringing Genomics to the Clinic” award, and the Legacy Laureate Award from the University of Pittsburgh. In addition to contributing to the media, Dr. Stephan has been featured twice on page A1 of the Wall Street Journal for his contributions to medicine.
Join us for this deep dive into the emerging space of persoanlized medicine and digital technologies.
Authors R. U. Sirius and Jay Cornell discuss their new book, Transcendence: the Disinformation Encyclopedia of Transhumanism and the Singularity.
In nearly ninety A-Z entries, Transcendence provides a multilayered look at the accelerating advances in artificial intelligence, cognitive science, genomics, information technology, nanotechnology, neuroscience, space exploration, synthetic biology, robotics, and virtual worlds that are making transhumanism a reality. Entries range from Cloning and Cyborg Feminism to Designer Babies and Memory-Editing Drugs. In addition, the book notes historical predecessors and personalities, both in mythology and history--ranging from Timothy Leary to Michael Jackson to Ray Kurzweil. It also introduces the culture around Transhumanism, covering all the geeky obsessions of the Transhumanist movement.
Want to get un-disinformed about Transhumanism and the Singularity?
Also, check out their site.
R. U. Sirius (Ken Goffman) is a writer, editor, and well-known digital iconoclast. He was co-publisher of the first popular digital magazine, Mondo 2000, from 1989-1993 and co-editor of the popular Book Mondo 2000: A user's Guide to the New Edge. He has written about technology and culture for Wired, Rolling Stone, and Boing Boing. He also lectures widely.
Jay Cornell is the former managing editor of h+ Magazine and senior web developer at Landkamer Partners.
Speaking of Green will interview this year's Ocean Exchange a couple of this year's honorees.
Dr. Tony Frudakis has a rich history as an emerging business expert and serial entrepreneur, focused on the commercial evolution of basic to applied science and disruptive technology development. He has public-company CEO experience, a background of successful corporate governance and SEC compliance, and is established as a cutting-edge science and technology thought leader. Dr. Frudakis is a Ph.D. graduate of the University of California, Berkeley (1995), and a Phi-Beta Kappa, Magna Cumme Laude graduate from the University of California, Irvine (1989). Since 1999, Dr. Frudakis has participated in the founding of four companies with technology innovations for genomics, homeland security, defense and clean energy. In 2012, he started Okeanos Technologies to develop and market an ultra-energy-efficient desalination technology that might become the next paradigm shift in water treatment systems. Dr. Frudakis is the author of 15 peer-reviewed scientific papers, a seminal textbook and 17 technology patent applications.
Mr. Anders Jansson is a Co- Founder and Ceo at Minesto. He has a proven entrepreneurial track record and has built up Minesto to what is today with offices in Sweden and UK. His focus on business development has gained traction on all continents, giving the company a global network within the renewable energy sector.
Dr. Roger Tiedemann is a scientist at the Ontario Cancer Institute and a hematologist specializing in multiple myeloma and lymphoma within the division of Medical Oncology and Hematology at the Princess Margaret Cancer Center and is an Assistant Professor of Medicine at the University of Toronto with appointments from the Department of Medical Biophysics and in the Department of Medicine. Dr. Tiedemann is a New Zealand-trained hematologist and fellow of both the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Hes an author of a US patent application for a new cell cycle therapeutic. His research focus includes multiple myeloma stems, progenitor cells, genomics and the development of new therapeutic strategies for myeloma based on an understanding of the tumor biology.
RSVP here! (or) mail firstname.lastname@example.org
Our guest today is Bob Dobbins, Vice President, New Business Development at Panasonic Corporation of North America. We will be talking to him today about Panasonic's upcoming Innovation HealthJam.
The Innovation HealthJam is a completely virtual event that brings together a diverse and knowledgeable group of people from the healthcare and technology fields to brainstorm ideas, improvements and innovation in healthcare. The event is co-hosted by a group of healthcare industry leaders and led by Panasonic's Innovation Group. Sponsors include leading healthcare industry organizations:
The American Medical Association
The Center for Technology and Aging
The Center for Information Technology Research in the Interest of Society (CITRIS)
Healthcare Information and Management Systems Society (HIMSS)
Personal Connected Health Alliancs (PCHA), a collaboration between Continua Health Alliance, mHealth Summit and HIMSS; along with technology providers Intel and Panasonic, and academic institutions UC Davis and UCSF
There are eight focus areas for the Jam:
Patient Engagement and Healthcare Design for Consumers
Technology and Older Adults: The New Era of Connected Aging
A Mobile Health Agenda for Transforming Healthcare Delivery
Compute for Personalized Medicine: Finding the Cause and Cure through Genomics
Telehealth and Telemedicine: Emerging Opportunities in Addressing the Triple Aim
Your Physician of the Future
Health Innovation for Vulnerable Populations - Worldwide
Remote Patient Monitoring (RPM)
Join us for an exciting discussion - Mr. Dobbins will be taking questions on air.
This episode is sponsored by Panasonic USA.
DNA mapping is it the gateway for Eugenics? Can we trust those who have used us?
"Assessing the work of Charles Darwin, and pondering the experience of animal breeders and horticulturists, Francis Galton wondered if the human genetic make-up could be improved: “The question was then forced upon me - Could not the race of men be similarly improved? Could not the undesirables be got rid of and the desirables multiplied?”This concept of eugenics - a term he introduced - soon won many adherents, notably in North America and England. First practical steps were taken in the United States of America. The government under Theodore Roosevelt created a national Heredity Commission that was charged to investigate the genetic heritage of the country and to “(encourage) the increase of families of good blood and (discourage) the vicious elements in the cross-bred American civilization”.
Don't be Educated in Ignorance!
Join in the conversation on I was just thinking... brought to you by the Caribbean Radio Show-The Knowlwdge Station every Friday evening 5-7pm pacific time and 8-10pm eastern time.
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.
Join Host Live Chats
- Freedom Doors Ministries (3 chatters)